These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
7. Drug information disclosed to patients prescribed antipsychotic medication. Benson PR J Nerv Ment Dis; 1984 Nov; 172(11):642-53. PubMed ID: 6149255 [TBL] [Abstract][Full Text] [Related]
8. Changing of Chinese psychiatrists' attitudes toward consent process to treatment and its association with the China's National Mental Health Law. Huang J; Shao Y; Ma H; Yang W; Li H Int J Psychiatry Med; 2019 Jan; 54(1):11-21. PubMed ID: 30122100 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome in Mexico. Montoya A; Ocampo M; Torres-Ruiz A Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509 [TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Joshi PT; Capozzoli JA; Coyle JT Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966 [TBL] [Abstract][Full Text] [Related]
12. Recognition, assessment and management of neuroleptic malignant syndrome. Khan M; Farver D S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275 [TBL] [Abstract][Full Text] [Related]
13. Psychiatrists' documentation of informed consent: a representative survey. Schachter D; Kleinman I Can J Psychiatry; 2006 Jun; 51(7):438-44. PubMed ID: 16838825 [TBL] [Abstract][Full Text] [Related]
14. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. Rodriguez OP; Dowell MS J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome: a preventive program. Fernando ML; Manchanda R; Kirk C J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827 [TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature. Seitz DP; Gill SS Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967 [TBL] [Abstract][Full Text] [Related]
17. Informed consent and tardive dyskinesia. Long-term follow-up. Kleinman I; Schachter D; Jeffries J; Goldhamer P J Nerv Ment Dis; 1996 Sep; 184(9):517-22. PubMed ID: 8831640 [TBL] [Abstract][Full Text] [Related]
18. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Perry PJ; Wilborn CA Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571 [TBL] [Abstract][Full Text] [Related]
19. Informing patients about tardive dyskinesia: A survey of clinicians' attitudes in three countries. Laugharne J; Davies A; Arcelus J; Bouman WP Int J Law Psychiatry; 2004; 27(1):101-8. PubMed ID: 15019771 [No Abstract] [Full Text] [Related]
20. Difficulties in obtaining informed consent by psychiatrists, surgeons and obstetricians/gynaecologists. Kent G Health Care Anal; 1996 Feb; 4(1):65-71. PubMed ID: 10158440 [No Abstract] [Full Text] [Related] [Next] [New Search]